Sign In

Save up to 80% by drug discount in your pharmacy with "Pharmacy Near Me - National Drug Discount Card"

You can scan QR Code(just open camera on your phone/scan by application) from the image on prescription drug discount card to save it to your mobile phone. Or just click on image if you're on mobile phone.

View Generic:
View Brand:

Acetaminophen diphenhydramine hcl - Medication Information

Product NDC Code 0363-9664
Drug Name

Acetaminophen diphenhydramine hcl

Type Generic
Pharm Class Histamine H1 Receptor Antagonists [MoA],
Histamine-1 Receptor Antagonist [EPC]
Active Ingredients
Acetaminophen 500 mg/1
Diphenhydramine hydrochloride 25 mg/1
Route ORAL
Dosage Form TABLET
RxCUI drug identifier 1092189
Application Number M013
Labeler Name WALGREENS CO.
Packages
Package NDC Code Description
0363-9664-37 375 tablet in 1 bottle (0363-9664-37)
0363-9664-60 125 tablet in 1 bottle (0363-9664-60)
Check if available Online

Overdosage of Acetaminophen Diphenhydramine HCL

Information about signs, symptoms, and laboratory findings of acute ovedosage and the general principles of overdose treatment.
Overdose warning In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222) . Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

Active ingredient

A list of the active, medicinal ingredients in the drug product.
Active ingredients (in each gelcap) Acetaminophen USP, 500mg Diphenhydramine HCL USP,25mg

Dosage and administration

Information about the drug product’s dosage and administration recommendations, including starting dose, dose range, titration regimens, and any other clinically sigificant information that affects dosing recommendations.
Directions ■ do not take more than directed (see overdose warning) adults and children 12 years and over ■ take 2 gelcaps at bedtime ■ do not take more than 2 gelcaps of this product in 24 hours children under 12 years ■ do not use

Inactive ingredient

A list of inactive, non-medicinal ingredients in a drug product.
Inactive ingredients colloidal silicon dioxide, croscarmellose sodium, D&C red#28, D&C yellow#10, FD&C blue#1, FD&C blue #2, FD&C red #40, FD&C yellow #6, gelatin, hydroxypropyl cellulose, hypromellose, isopropyl alcohol, microcrystalline cellulose, n-butyl alcohol, povidone, pregelatinized starch, propylene glycol, shellac glaze, stearic acid, titanium dioxide, triacetin.

Indications and usage

A statement of each of the drug products indications for use, such as for the treatment, prevention, mitigation, cure, or diagnosis of a disease or condition, or of a manifestation of a recognized disease or condition, or for the relief of symptoms associated with a recognized disease or condition. This field may also describe any relevant limitations of use.
Uses temporary relief of occasional headaches and minor aches and pains with accompanying sleeplessness

Purpose

Information about the drug product’s indications for use.
Purposes Pain reliever Nighttime sleep aid

Spl product data elements

Usually a list of ingredients in a drug product.
Acetaminophen Diphenhydramine HCL Acetaminophen Diphenhydramine HCL ACETAMINOPHEN ACETAMINOPHEN HYPROMELLOSE 2208 (100 MPA.S) STARCH, CORN TITANIUM DIOXIDE FD&C YELLOW NO. 6 DIPHENHYDRAMINE HYDROCHLORIDE DIPHENHYDRAMINE STEARIC ACID CROSCARMELLOSE SODIUM FD&C RED NO. 40 GELATIN ISOPROPYL ALCOHOL MICROCRYSTALLINE CELLULOSE D&C YELLOW NO. 10 BUTYL ALCOHOL PROPYLENE GLYCOL SILICON DIOXIDE D&C RED NO. 28 FD&C BLUE NO. 1 FD&C BLUE NO. 2 HYDROXYPROPYL CELLULOSE, UNSPECIFIED POVIDONE SHELLAC TRIACETIN Encapsulated gray color tablets with dark blue opaque and light blue opaque hard gelatin shells G3

Package label principal display panel

The content of the principal display panel of the product package, usually including the product’s name, dosage forms, and other key information about the drug product.
Principal Display Panel 125 label

Ask doctor

Information about when a doctor should be consulted about existing conditions or sumptoms before using the drug product, including all warnings for persons with certain preexisting conditions (excluding pregnancy) and all warnings for persons experiencing certain symptoms. The warnings under this heading are those intended only for situations in which consumers should not use the product until a doctor is consulted.
Ask a doctor before use if you have ■ liver disease ■ a breathing problem such as emphysema or chronic bronchitis ■ trouble urinating due to an enlarged prostate gland ■ glaucoma

Ask doctor or pharmacist

Information about when a doctor or pharmacist should be consulted about drug/drug or drug/food interactions before using a drug product.
Ask a doctor or pharmacist before use if you are ■ taking the blood thinning drug warfarin ■ taking sedatives or tranquilizers

Do not use

Information about all contraindications for use. These contraindications are absolute and are intended for situations in which consumers should not use the product unless a prior diagnosis has been established by a doctor or for situations in which certain consumers should not use the product under any circumstances regardless of whether a doctor or health professional is consulted.
Do not use ■ with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. ■ with any other product containing diphenhydramine, even one used on skin ■ in children under 12 years of age ■ if you have ever had an allergic reaction to this product or any of its ingredients

Keep out of reach of children

Information pertaining to whether the product should be kept out of the reach of children, and instructions about what to do in the case of accidental contact or ingestion, if appropriate.
Keep out of reach of children Keep out of reach of children

Questions

A telephone number of a source to answer questions about a drug product. Sometimes available days and times are also noted.
Questions or comments? call 1-877-770-3183 Mon-Fri 8:00 AM EST to 5:00 PM PST.

Stop use

Information about when use of the drug product should be discontinued immediately and a doctor consulted. Includes information about any signs of toxicity or other reactions that would necessitate immediately discontinuing use of the product.
Stop use and ask a doctor if ■ sleeplessness persists continuously for more than 2 weeks. Insomnia may be a symptom of serious underlying medical illness. ■ pain gets worse or lasts more than 10 days ■ fever gets worse or lasts more than 3 days ■ redness or swelling is present ■ new symptoms occur These could be signs of a serious condition.

When using

Information about side effects that people may experience, and the substances (e.g. alcohol) or activities (e.g. operating machinery, driving a car) to avoid while using the drug product.
When using this product ■ drowsiness will occur ■ avoid alcoholic drinks ■ do not drive a motor vehicle or operate machinery

Pregnancy or breast feeding

Pregnancy or Breast feeding
If pregnant or breast-feeding, ask a health professional before use.

Storage and handling

Information about safe storage and handling of the drug product.
Other information ■ store between 20°-25°C (68°-77°F). See USP Controlled Room Temperature. ■ see bottom of the label for expiration date and lot number.

Warnings

Information about serious adverse reactions and potential safety hazards, including limitations in use imposed by those hazards and steps that should be taken if they occur.
Liver warning This product contains acetaminophen. Severe liver damage may occur if you take ■ more than 4,000 mg of acetaminophen in 24 hours ■ with other drugs containing acetaminophen ■ 3 or more alcoholic drinks every day while using this product Allergy alert acetaminophen may cause severe skin reactions. Symptoms may include: ■ skin reddening ■ blisters ■ rash If a skin reaction occurs, stop use and seek medical help right away.

Disclaimer: Do not rely on openFDA or Phanrmacy Near Me to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Source: OpenFDA, Healthporta Drugs API